Home Newsfeeds Loop Capital Downgrades Corteva to Hold, Raises Price Target to $71

Loop Capital Downgrades Corteva to Hold, Raises Price Target to $71

Loop Capital analyst Christopher Kapsch downgrades Corteva (NYSE:CTVA) from Buy to Hold and raises the price target from $70 to $71.

byBenzinga Newsdesk

November 15, 2022

1 minute read

Loop Capital analyst Christopher Kapsch downgrades Corteva (NYSE:CTVA) from Buy to Hold and raises the price target from $70 to $71.

German Rival Alfaview Files EU Antitrust Complaint Against Microsoft Over Teams Bundling

By Anusuya Lahiri

July 21, 9:37 AM

German rival Alfaview launched an EU antitrust complaint on Microsoft Corp (NASDAQ: MSFT) this week, marking the bloc regulator's second over its bundling of video app Teams into

CRM

Circle’s Complaints About Binance’s Reserve Mismanagement Lead To New York Regulator’s Action

By Murtuza Merchant

February 13, 7:06 PM

Stablecoin issuer Circle Internet Financial Ltd. (CRYPTO: USDC) complained to the New York State Department of Financial Services (NYDFS) last year about its rival, Binance, and its mismanagement of reserves for its own tokens (CRYPTO: B

$BUSD

Morgan Stanley Upgrades Box to Overweight, Raises Price Target to $34

By Benzinga Newsdesk

October 3, 6:14 AM

Morgan Stanley analyst Josh Baer upgrades Box (NYSE:BOX) from Equal-Weight to Overweight and raises the price target from $32 to $34.

BOX

Wana Brands’ Cannabis Gummies Now Available Via Canopy Growth’s Spectrum Therapeutics

By Vuk Zdinjak

July 27, 10:28 AM

Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) announced that cannabis gummies from Wana Brands, are now available through Spectrum Therapeutics - Canopy Growth's medical cannabis division.

CGC

Loop Capital Downgrades Corteva to Hold, Raises Price Target to $71

Related Posts

German Rival Alfaview Files EU Antitrust Complaint Against Microsoft Over Teams Bundling

Circle’s Complaints About Binance’s Reserve Mismanagement Lead To New York Regulator’s Action

Morgan Stanley Upgrades Box to Overweight, Raises Price Target to $34

Wana Brands’ Cannabis Gummies Now Available Via Canopy Growth’s Spectrum Therapeutics